Engineering, Master, and Working cell bank generation with full
characterization, qualified storage, and the documentation regulators expect — across adherent and suspension platforms.
We generate, characterize, and store Engineering, Master, and Working cell banks in parallel with your R&D, process development, and manufacturing workstreams — across a wide range of cell types, from naïve cells through producer lines — with the documentation and quality systems that regulators expect.
A characterized cell bank pipeline that scales with the program — from research-grade engineering banks through qualified working banks for routine clinical and commercial production.
The full set of capabilities that make up our integrated CDMO platform.
SynBio research, ML-driven optimization, proprietary tools for next-gen therapies.
End-to-end autologous & allogeneic workflows — CAR-T, NK, Treg, in-vivo GT.
Adherent & suspension lentivirus — 2 L to 200 L GMP. Targeting and control built in.
Knowledge transfer as a discipline. Development-to-GMP in ~7 months.
Dedicated PMO, transparent Gantts, real-time data exchange. One accountable team.
